Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Sobel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
Human Immunology|January 26, 2011
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African AmericansAleksandr Lazaryan, Wei Song, Elena Lobashevsky, et al.
Obstetrics and Gynecology|August 2, 2007
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trialCharles H Livengood, Daron G Ferris, Harold C Wiesenfeld, et al.
Journal of Virology|December 25, 2009
Human leukocyte antigen class I supertypes and HIV-1 control in African AmericansAleksandr Lazaryan, Wei Song, Elena Lobashevsky, et al.
Cell Host & Microbe|August 14, 2015
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1RaMonica Borghi, Antonella De Luca, Matteo Puccetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubtElias J Anaissie, Brahm H Segal, John R Graybill, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Obstetrics and Gynecology|May 27, 2010
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler, Sherry L Farr, John M Karon, et al.
Human Immunology|January 26, 2011
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African AmericansAleksandr Lazaryan, Wei Song, Elena Lobashevsky, et al.
Obstetrics and Gynecology|August 2, 2007
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trialCharles H Livengood, Daron G Ferris, Harold C Wiesenfeld, et al.
Journal of Virology|December 25, 2009
Human leukocyte antigen class I supertypes and HIV-1 control in African AmericansAleksandr Lazaryan, Wei Song, Elena Lobashevsky, et al.
Cell Host & Microbe|August 14, 2015
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1RaMonica Borghi, Antonella De Luca, Matteo Puccetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubtElias J Anaissie, Brahm H Segal, John R Graybill, et al.
Pageof 3